Product NDC: | 52544-958 |
Proprietary Name: | Fioricet with Codeine |
Non Proprietary Name: | butalbital, acetaminophen, caffeine, and codeine phosphate |
Active Ingredient(s): | 325; 50; 40; 30 mg/1; mg/1; mg/1; mg/1 & nbsp; butalbital, acetaminophen, caffeine, and codeine phosphate |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52544-958 |
Labeler Name: | Watson Pharma, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020232 |
Marketing Category: | NDA |
Start Marketing Date: | 19920730 |
Package NDC: | 52544-958-01 |
Package Description: | 100 CAPSULE in 1 BOTTLE (52544-958-01) |
NDC Code | 52544-958-01 |
Proprietary Name | Fioricet with Codeine |
Package Description | 100 CAPSULE in 1 BOTTLE (52544-958-01) |
Product NDC | 52544-958 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | butalbital, acetaminophen, caffeine, and codeine phosphate |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19920730 |
Marketing Category Name | NDA |
Labeler Name | Watson Pharma, Inc. |
Substance Name | ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE |
Strength Number | 325; 50; 40; 30 |
Strength Unit | mg/1; mg/1; mg/1; mg/1 |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC],Barbiturate [EPC],Barbiturates [Chemical/Ingredient],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient] |